Boston Cell Standards’ immunohistochemistry reference materials have entered the FDA’s Medical Device Development Tools qualification phase, advancing efforts to standardize IHC assay performance in cancer diagnostics.
These products are for the calibration verification of clinical systems testing for total protein and albumin in both urine and CSF samples.
Verichem's is offering liquid stable kits of clinical reference materials intended for the calibration verification of electrolyte assays.
Verichem offers an extensive array of liquid stable and ready-to-use multi-level reference materials for total cholesterol, HDL, and LDL testing.
Read More
Verichem Laboratories now offers an extensive selection of ready-to-use, liquid stable carbon dioxide reference materials.
Read More
Verichem bilirubin standards are liquid stable and ready to use and do not require any reconstitution, supplemental diluents, or dilution procedures.
Read More
Verichem’s clinical reference materials meet all CLIA, CAP, and CLSI recommendations for verification materials with known values.
Read More
SeraCare Life Sciences has expanded its suite of clinical genomics development, validation, and quality control tools with the launch of the Seraseq breast copy number variation (CNV) mix and Seraseq lung and brain CNV mix.
Read More
The materials enable simplified validation of panel tests performed via next-generation sequencing.
Read More